Is BCAL Diagnostics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, BCAL Diagnostics Ltd (BDX.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is BCAL Diagnostics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BCAL Diagnostics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of BCAL Diagnostics Ltd?

Muslim investors may consider investing in BCAL Diagnostics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is BCAL Diagnostics Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of BCAL Diagnostics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for BCAL Diagnostics Ltd updated?

The Shariah compliance status of BCAL Diagnostics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like BCAL Diagnostics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of BCAL Diagnostics Ltd?

You can check the latest Shariah compliance status of BCAL Diagnostics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BDX.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 28, 2025

Report Source: 2025 2nd Quarter Report

BCAL Diagnostics Ltd. Stock Analysis BDX.AX

Australia Health Care Nano Cap Report: Q2, 2025

BCAL Diagnostics Ltd. is a biotechnology company, which develops screening tests for the early diagnosis and monitoring of breast cancer. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-07-21. The firm develops early, non-invasive blood test-based diagnostic technologies designed to complement mammograms and improve breast cancer screening outcomes. Its commercial laboratory, equipped with Liquid Chromatography Mass Spectrometry (LCMS) technology, is focused on scientific innovation and clinical service delivery, supporting both ongoing research and the commercial rollout of our diagnostic test. The firm develops a blood test for breast cancer screening and diagnosis. The assay measures a panel of lipids in blood plasma using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Its lipid measurements are converted to a test score using a proprietary diagnostic algorithm. The company offers BREASTEST plus, which is a blood test designed to be used alongside a mammogram in breast cancer screening. The company provides information for women with dense breasts to help rule out the presence of breast cancer.

Key Statistics of BCAL Diagnostics Ltd (BDX.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.08AUD0.08

Today's Open

AUD0.08

Volume

64.42K

P/E Ratio (TTM)

52 Week Range

AUD0.05AUD0.16

Market Cap

27.65M

Avg. Volume

56.50K

Dividend Yield

Financial Metrics & Statements of BCAL Diagnostics Ltd (BDX.AX)

FAQ's for BCAL Diagnostics Ltd (BDX.AX)

According to Musaffa’s Shariah screening methodology, BCAL Diagnostics Ltd (BDX.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.